Implementation and effectiveness of a telemedicine platform among patients with rare diseases and their caregivers: A non-randomized controlled study
This non-randomized controlled study found that while a telemedicine platform for rare disease patients and caregivers did not significantly improve quality of life or depression compared to in-person care, it substantially increased treatment satisfaction and reduced healthcare costs, despite facing technical and administrative implementation barriers.